2',6',4''-trichloro-4'-methylbenzophenone | 99508-23-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2',6',4''-trichloro-4'-methylbenzophenone
• 英文别名: 4-(4-chlorobenzoyl)-3,5-dichlorotoluene；4-(4-Chlorobenzoyl) 3,5-dichlorotoluene；(4-chlorophenyl)-(2,6-dichloro-4-methylphenyl)methanone
• CAS: 99508-23-3
• 化学式: C₁₄H₉Cl₃O
• 分子量: 299.584
• InChiKey: QEHZHMRMAWRGGN-UHFFFAOYSA-N

物化性质

• 沸点：
  428.0±45.0 °C(Predicted)
• 密度：
  1.363±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2',6',4''-trichloro-4'-methylbenzophenone 在 N-溴代丁二酰亚胺(NBS) 、 sodium azide 、 sodium methylate 、 过氧化苯甲酰 作用下， 以 乙醇 、 苯 为溶剂， 反应 30.33h， 生成 5-氨基-1-(3,5-二氯-4-(4-氯苯甲酰基)苄基)-1H-1,2,3-三氮唑-4-甲酰胺
  参考文献：
  名称：

  Bochis; Chabala; Harris, Journal of Medicinal Chemistry, 1991, vol. 34, # 9, p. 2843 - 2852

  摘要：

  DOI：
• 作为产物：
  描述：

  2,6-二氯-4-甲基苯甲酸 在 三氯化铝 、 氯化亚砜 、 N,N-二甲基甲酰胺 作用下， 以 四氯化碳 为溶剂， 反应 18.0h， 生成 2',6',4''-trichloro-4'-methylbenzophenone
  参考文献：
  名称：

  Bochis; Chabala; Harris, Journal of Medicinal Chemistry, 1991, vol. 34, # 9, p. 2843 - 2852

  摘要：

  DOI：

文献信息

• 5-amino or substituted amino 1,2,3-triazoles
  申请人：Merck & Co., Inc.

  公开号：US04590201A1

  公开（公告）日：1986-05-20

  Novel 5-amino or substituted amino 1,2,3-triazoles are disclosed as having anticoccidial activity. The compounds are useful for controlling coccidiosis when administered in minor quantities to animals, in particular to poultry, usually in admixture with animal sustenance.

  小说中披露了具有抗球虫活性的5-氨基或取代氨基1,2,3-三唑。这些化合物在与动物饲料混合后以微量给动物，特别是家禽，用于控制球虫病非常有效。
• Method for inhibiting metalloproteinase expression
  申请人：The United States of America as represented by the Department of Health

  公开号：US05602156A1

  公开（公告）日：1997-02-11

  Calcium homeostasis is an important regulator of MMP-2 transcription, activation and activity. Disclosed herein are compounds which inhibit the expression of matrix metalloproteinases in cells. Pharmaceutical application of these compounds to inhibit the expression of MMPs offers a new approach to cancer treatment as well as treatment for nerve healing, degenerative cartilagenous diseases, decubitus ulcers, arthritis, Alzheimer's disease, wound healing, proliferative retinopathy, proliferative renal diseases, corneal ulcers and fertility problems.

  钙稳态是MMP-2转录、激活和活性的重要调节因素。本文公开了一些抑制细胞中基质金属蛋白酶表达的化合物。这些化合物在制药应用中用于抑制MMPs的表达，提供了癌症治疗以及治疗神经愈合、退行性软骨病、褥疮、关节炎、阿尔茨海默病、伤口愈合、增生性视网膜病变、增生性肾脏疾病、角膜溃疡和生育问题的新方法。
• Method for inhibiting angiogenesis
  申请人：United States of America

  公开号：US05744492A1

  公开（公告）日：1998-04-28

  Angiogenesis is a composite of regulated proliferation and regulated invasion occuring in a variety of normal and pathologic conditions. Compound 1 and related analogs are useful for inhibiting angiogenesis in a host and offer a novel approach to the treatment of cancer, diabetic retinopathy, hemangiomata, vasculidities and other diseases associated with angiogenesis.

  血管新生是在多种正常和病理情况下发生的受调节增殖和调节侵袭的复合过程。化合物1及其相关类似物对于抑制宿主中的血管新生非常有用，并提供了治疗癌症、糖尿病视网膜病变、血管瘤、血管炎和其他与血管新生有关的疾病的新方法。
• Combination therapy using signal transduction inhibitors with paclitaxel
  申请人：The United States of America as represented by the Department of Health

  公开号：US05565478A1

  公开（公告）日：1996-10-15

  The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of formula I defined herein in combination with paclitaxel or other modified taxane analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.

  本发明提供了一种用于治疗患者癌症的组合物和方法，其中公式I所定义的化合物与紫杉醇或其他修饰的紫杉烷类似物结合使用，能够提供比单独使用这些化合物更强的抗癌效果。
• Inhibition of retroviral LTR promoters by calcium response modifiers
  申请人：The United States of America as represented by the Department of Health

  公开号：US06057346A1

  公开（公告）日：2000-05-02

  A class of calcium-response modification compounds is disclosed which inhibits the activation of retroviral LTR promoters, including the HIV-LTR. This class of compounds are used to delay or suppress the transition of a retroviral infection from a latent to a virulent condition, thereby ameliorating retrovirally caused diseases such as AIDS. The compounds are also useful in cancer treatment, allowing for coordinated therapeutic approaches to retroviral diseases and related cancers such as AIDS and Kaposi's Sarcoma. The compounds are also useful in standardizing in vitro assays of clinical and experimental importance.

  本发明揭示了一类钙响应修饰化合物，该化合物抑制逆转录病毒LTR启动子的激活，包括HIV-LTR。这类化合物用于延迟或抑制逆转录病毒感染从潜伏状态到致病状态的转变，从而改善逆转录病毒引起的疾病，如艾滋病。该化合物还可用于癌症治疗，允许协调治疗逆转录病毒疾病和相关癌症，如艾滋病和卡波西肉瘤。该化合物还可用于标准化临床和实验重要性的体外测定。